News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Publication Jun 3, 2024 Scoring Indices for Perianal Fistulising Crohn’s Disease: A Systematic Review Read Now
Publication Apr 23, 2024 Pharmacological Therapies for the Management of Fistulizing Crohn’s Disease: A Systematic Review and Meta-Analysis Read Now
Publication Mar 4, 2024 Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn’s disease on intestinal ultrasound Read Now
Publication Mar 1, 2024 Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn’s Disease Clinical Trials Read Now
Publication Feb 28, 2024 Identification of immune cell markers associated with ulcerative colitis histological disease activity in colonic biopsies Read Now
Publication Feb 8, 2024 Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial Read Now
